The first Trillium Therapeutics trade was made in Q4 2015.
Since then Jim Simons bought shares four more times and sold shares on seven occasions. The investor completely sold their stake between Q3 2020 and Q1 2021.
Avg closing price
Price range
Sold -26 Thousand shares
Q1 2021
Avg closing price
$12.37
Price range
$9.86
-
$15.51
Sold 86.2% shares (-162 Thousand shares)
Q4 2020
Avg closing price
$14.42
Price range
$11.63
-
$20.13
Sold 47.0% shares (-167 Thousand shares)
Q3 2020
Avg closing price
$9.97
Price range
$6.56
-
$16.00
New holding (+355 Thousand shares)
Q2 2020
Avg closing price
$6.19
Price range
$3.53
-
$9.43
Sold -116 Thousand shares
Q4 2018
Avg closing price
$3.00
Price range
$1.65
-
$5.65
Sold 19.4% shares (-27.9 Thousand shares)
Q3 2018
Avg closing price
$5.64
Price range
$4.85
-
$6.55
Increased shares by 245.3% (+102 Thousand shares)
Q2 2018
Avg closing price
$6.37
Price range
$5.48
-
$7.40
Sold 73.4% shares (-115 Thousand shares)
Q1 2018
Avg closing price
$7.58
Price range
$6.68
-
$8.80
New holding (+157 Thousand shares)
Q4 2017
Avg closing price
$8.28
Price range
$5.15
-
$12.35
Sold -25.5 Thousand shares
Q2 2016
Avg closing price
$10.39
Price range
$8.56
-
$12.95
Increased shares by 5.7% (+1.38 Thousand shares)
Q1 2016